Navigation Links
Huntsworth plc Releases Interim Statement on First Quarter 2008
Date:5/16/2008

well with a very satisfactory first quarter which has continued into the beginning of Quarter 2. The Group's financial position remains strong, further strengthened in February by the disposal of CapitalBridge, a non-core company, for US$31.7 million in cash. Having 80% of our forecast revenue committed at this early stage gives us considerable confidence for the year ahead."

Huntsworth plc will be announcing its interim results for the six months ended 30 June 2008 on Thursday 28 August 2008. A presentation for analysts will be held at 9.00am at the offices of Numis Securities Limited, 5th Floor, London Stock Exchange, 10 Paternoster Square, London, EC4M 7LT.

About Huntsworth plc

Huntsworth plc (LSE: HNT), is a leading international public relations and healthcare communications group, with a portfolio of premier brands in communications serving global customers. Operating from 70 principal offices in 31 countries, Huntsworth meets the sophisticated demands of its clients both domestically and internationally by offering excellence within each of the Huntsworth's four core disciplines: Financial & Corporate Communications, Public Affairs, Public Relations and Healthcare Communications. As of year end 2007, the Huntsworth international client base included: 52 companies in the FTSE 100, 110 companies in the Fortune 500 and 131 companies in the Eurotop 300.

In the US, Huntsworth companies include a number of healthcare communication firms, including Dorland Global, AXIOM, evoke interactive, ApotheCom, Brand Health International, Helix and Curatio CME Institute, as well as Grayling Global (formerly The Global Consulting Group), an international public relations, public affairs and investor relations firm, The Red Consultancy, an international public relations firm, and Citigate Cunningham a technology public relations firm.

Contact:

Sally Withey

Chief Operating Officer

+44 (0)20 7224 8778

+44 (0)78 999
'/>"/>

SOURCE Huntsworth plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Dawning Technologies, Inc. Releases JavaLin/PDI Portable Device Interface
2. Integrated Benefits Institute Releases Research on True Cost of Absence for Employers
3. WebReach, Inc. Releases Mirth 1.7.1 - The Linux of Healthcare Now Supports Digital Imaging in Medicine (DiCOM) Standard
4. The Leapfrog Group Releases 2008 Hospital Survey Offering Consumers Greater Assurance of Safety
5. Grocery Manufacturers Association Releases Science Policy Paper on Bisphenol A
6. Blue Cross and Blue Shield of Minnesota Releases 2007 Financial Results
7. MassMutuals Center for Behavioral Research(SM) Releases White Paper on Best Practices in Education Campaigns
8. Patient Centered Primary Care Collaborative Releases New Guidelines for Health Care Purchasers
9. Academy of General Dentistry Releases Updated Employment Statistical Map
10. Health Monitoring Systems Releases EpiCenter(TM)
11. Wellcorps International Releases Major Paper on History and Evolution of Amphetamine and Anti-Depressant Use in America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)...wswire-USNewswire/ -- Steven Mosher,president of ... America has,a hidden problem of sex discriminatio...use to address., In PRI,s latest YouTube video, M...th Asian countries, of sex-selective abortion. Acc...ready claimed the lives of over 100,million girls ...
(Date:7/24/2008)...ard-Winning Web Site Attracts,Interactive Audience...Health-conscious,consumers looking for a healthy a...es at the National Turkey Federation,s (NTF) upgra...: http://www.newscom.com/cgi-bin/prnh/20080724/NY... redesigned homepage, including a,Consumer Hot Pla...
(Date:7/24/2008)...ting firm CPEhr, and Junior Achievement, a non-pro...igh-students from Downtown Business Magnets High S...aw, interviewing techniques and more. , ..., 2008 -- Los Angeles HR Consulting firm CPEhr, ... hosted a Job Shadow Day for 30 high-students from...
(Date:7/24/2008)...om manufacturing company has introduced a new prod...e is a utility panel which can be integrated into ...earance. , Burnsville, Mi... designer, fabricator and installer of cleanroom s... a utility panel for integration into its AireCell...
Breaking Medicine News(10 mins):Health News:PRI: Pro-Life Leader Blames Feminist Groups for Slaughter of Girls 2Health News:EatTurkey.com Gets a Healthy Upgrade 2Health News:CPEhr and Junior Achievement Prepare High-School Students For the Workforce 2Health News:CPEhr and Junior Achievement Prepare High-School Students For the Workforce 3Health News:Gerbig Engineering Announces Availability of Cleanroom Utility Panel 2
...r researchers have developed a new strain of mice ... certain gene contributes to a particularly deadly...of the strain by its developers at the Ohio State ... (OSUCCC) suggests that the genetic change comes e...
... blame yourself, if your taste buds get tickled at...re mention! A recent investigation into the reaso...arian food has shown that such tendencies are gene...rs opine that, this could be the only way, the bod...
...umber of cases of kidney cancer has been rising ov... University of Michigan Comprehensive Cancer Cente...the detection of small, presumably curable, kidney... been paralleled by greater use of surgery for kid...
...very diabetic person in Mumbai, there is one with ...in the disease with sugar levels higher than norma...umbaikars, which is also the incidence for pre-dia... Shashank Joshi. The occurrence of diabetes is goi...
Other Medicine News:Health News:Mouse Gene With Gene Stutter Will Help Leukemia Research 2Health News:Mouse Gene With Gene Stutter Will Help Leukemia Research 3Health News:More Kidney Cancer Is Detected and Treated Early, Yet Death Rate Rises 2Health News:More Kidney Cancer Is Detected and Treated Early, Yet Death Rate Rises 3
(Date:7/23/2008)...swire-FirstCall/ -- Dendreon Corporation,(Nasdaq: ...ndent Data,Monitoring Committee (IDMC) to review i...vival relating to the Company,s Phase 3 IMPACT (IM... also known as D9902B) clinical trial,of PROVENGE(...tigational,active cellular immunotherapy for the t...
(Date:7/22/2008)...RNewswire/ -- Nonin Medical, a leading innovator,o... 20 years, has entered,the clinical testing phase ...al oxygen saturation. Today,s most common applicat...ng of the regional blood oxygenation,in the brain ...comes from an ongoing clinical study at the,Duke U...
(Date:7/22/2008)...dy Confirms Tyrima Exhibits Excellent Drug-Like ...sults Support Initiation of Phase II Clinical Tria...wswire/ -- CeNeRx BioPharma,Inc., a clinical stag...e,treatments for diseases of the central nervous s...andidate Tyrima(TM) into Phase II trials for the,t...
(Date:7/22/2008)...th chemotherapy and pegylated enzyme produces s...erapy alone - - Pegylated enzyme ...FirstCall/ -- Halozyme Therapeutics,Inc. (Nasdaq:...nd,commercializing products targeting the extracel...positive pre-clinical animal efficacy data,for its...
Breaking Medicine Technology:Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 4Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 2Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 3Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 4Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 5Aflac and the American Association for Cancer Research Unite to Issue Inaugural Aflac Career Development Award for Childhood Cancer Research 4933 1Aflac and the American Association for Cancer Research Unite to Issue Inaugural Aflac Career Development Award for Childhood Cancer Research 4933 2Aflac and the American Association for Cancer Research Unite to Issue Inaugural Aflac Career Development Award for Childhood Cancer Research 4933 3Knowledge Based Reconstruction Demonstrates Accuracy in Obtaining Ventricular Volume and Function in Tetralogy of Fallot Patients According to Ventri 1921 1Knowledge Based Reconstruction Demonstrates Accuracy in Obtaining Ventricular Volume and Function in Tetralogy of Fallot Patients According to Ventri 1921 2Alexza Announces Positive Phase 1 Results With AZ 007 28Staccato 28R 29 Zaleplon 29 1919 1Alexza Announces Positive Phase 1 Results With AZ 007 28Staccato 28R 29 Zaleplon 29 1919 2Alexza Announces Positive Phase 1 Results With AZ 007 28Staccato 28R 29 Zaleplon 29 1919 3Alexza Announces Positive Phase 1 Results With AZ 007 28Staccato 28R 29 Zaleplon 29 1919 4Measurements Poor for Assessing Clinical Trials With Children 17915 1Measurements Poor for Assessing Clinical Trials With Children 17915 2
....H.--(BUSINESS WIRE)--May 24, 2007 - Bentley,Pharm...utical,company, today announced that a late breaki...pted for a poster presentation at the,American Dia...ago.,The abstract, entitled "Results of a Randomiz...y of Intranasal Insulin Spray,(Nasulin(TM)) and In...
...O, May 23, 2007 /PRNewswire-FirstCall/ -- Shire pl...of the,investigational medication guanfacine exten...), a selective,alpha-2A-adrenoceptor agonist. Thes...olled studies and two long-term phase III,open-lab...tric,Association (APA) annual meeting, demonstrate...
Other Medicine Technology:Bentley Late Breaking Abstract Accepted for Poster Presentation at,American Diabetes Association Scientific Sessions 2Bentley Late Breaking Abstract Accepted for Poster Presentation at,American Diabetes Association Scientific Sessions 3Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 2Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 3Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 4Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 5Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 6Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 7Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 8
...nts incorporate a layered design unique in the ind...to prevent stray electrosurgical burns along the s...e or capacitive coupling; a well-documented patien...l AEM Instruments provides a neutral return path f...
...nts incorporate a layered design unique in the ind...to prevent stray electrosurgical burns along the s...e or capacitive coupling; a well-documented patien...l AEM Instruments provides a neutral return path f...
...nts incorporate a layered design unique in the ind...to prevent stray electrosurgical burns along the s...e or capacitive coupling; a well-documented patien...l AEM Instruments provides a neutral return path f...
...nts incorporate a layered design unique in the ind...to prevent stray electrosurgical burns along the s...e or capacitive coupling; a well-documented patien...l AEM Instruments provides a neutral return path f...
Medicine Products: